Diagnostic products maker Qiagen NV said Wednesday that it will work with Eli Lilly and Co. to develop new tests that could identify patients who could be helped by Lilly’s drugs.
The companies did not disclose terms of the new collaboration, but described it as a “broad” partnership that will cover “all therapeutic areas.”
{iframe}http://www.pharmpro.com/news/2013/02/qiagen-and-lilly-expand-diagnostic-partnership{/iframe}